These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18580638)

  • 1. Epidural or I.V.? Tubing trouble.
    Cohen MR
    Nursing; 2008 Jul; 38(7):17. PubMed ID: 18580638
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary pulmonary hypertension treated with short-term epoprostenol infusion.
    Shiota Y; Mikawa Y; Arikita H; Nakashima T; Horita N; Hiyama J; Ono T; Yamakido M
    Intern Med; 2003 Sep; 42(9):824-6. PubMed ID: 14518669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient safety challenges in treprostinil therapy.
    Roncesvalles A; Lee FW; Camamo J; Priestley G
    Medsurg Nurs; 2008 Apr; 17(2):101-6. PubMed ID: 18517170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pulmonary artery hypertension: when life hangs by a thread].
    Houde J
    Perspect Infirm; 2010; 7(3):22-6. PubMed ID: 21744581
    [No Abstract]   [Full Text] [Related]  

  • 5. Endothelin-1 across the lung circulation in patients with pulmonary arterial hypertension and influence of epoprostenol infusion.
    Selimovic N; Andersson B; Bergh CH; Sakiniene E; Carlsten H; Rundqvist B
    J Heart Lung Transplant; 2009 Aug; 28(8):808-14. PubMed ID: 19632577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous catheter infections in pulmonary arterial hypertension.
    Gaine S; Gomberg-Maitland M
    Int J Clin Pract Suppl; 2008 Jul; (160):3-4. PubMed ID: 18638169
    [No Abstract]   [Full Text] [Related]  

  • 7. Pulmonary hypertension and beta-thalassemia major: report of a case, its treatment, and a review of the literature.
    Tam DH; Farber HW
    Am J Hematol; 2006 Jun; 81(6):443-7. PubMed ID: 16680745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The "bouncing" catheter.
    Malaczynska-Rajpold K; Kurzyna M; Koteja A; Torbicki A; Mularek-Kubzdela T
    Cardiol J; 2016; 23(5):552-553. PubMed ID: 27723062
    [No Abstract]   [Full Text] [Related]  

  • 9. Advances in prostanoid infusion therapy for pulmonary arterial hypertension.
    Doran A; Harris S; Goetz B
    J Infus Nurs; 2008; 31(6):336-45. PubMed ID: 19018187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostacyclin withdrawal in pulmonary hypertension #264.
    Bartlett C; Landzaat L;
    J Palliat Med; 2013 Feb; 16(2):204-5. PubMed ID: 23336356
    [No Abstract]   [Full Text] [Related]  

  • 11. [The first LENUS pro® pump implantation in Poland in patient with pulmonary hypertension].
    Pawlak A; Koteja A; Starska A; Kurzyna M; Gil RJ
    Kardiol Pol; 2016; 74(3):300. PubMed ID: 27004544
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapy for primary pulmonary hypertension.
    McCormack D
    Can Respir J; 2003 Apr; 10(3):169-70. PubMed ID: 12712230
    [No Abstract]   [Full Text] [Related]  

  • 13. Flolan infusion interruption: a lethal complication during venous access.
    Falk A; Lookstein RA; Mitty HA
    J Vasc Interv Radiol; 2001 May; 12(5):667-8. PubMed ID: 11340154
    [No Abstract]   [Full Text] [Related]  

  • 14. Bloodstream infections due to Micrococcus spp and intravenous epoprostenol.
    Valdivia-Arenas MA
    Infect Control Hosp Epidemiol; 2009 Dec; 30(12):1237. PubMed ID: 19888847
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical Complications with the Delivery of Inhaled Epoprostenol in the Operating Room.
    Bhatt AM; Stein EJ
    Anesthesiology; 2017 Aug; 127(2):383. PubMed ID: 28323647
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful transition from intravenous to inhaled prostacyclin in a patient with pulmonary hypertension and right ventricular failure.
    Reddy MT; Patel H; Ventura HO
    Congest Heart Fail; 2008; 14(5):285-6. PubMed ID: 18983294
    [No Abstract]   [Full Text] [Related]  

  • 17. Overdosing with prostacyclin in primary pulmonary hypertension.
    Wasserman K; Oudiz R
    J Am Coll Cardiol; 2000 Jun; 35(7):1995-6. PubMed ID: 10841256
    [No Abstract]   [Full Text] [Related]  

  • 18. Pulmonary hypertension trials: current end points are flawed, but what are the alternatives?
    Roberts K; Preston I; Hill NS
    Chest; 2006 Oct; 130(4):934-6. PubMed ID: 17035418
    [No Abstract]   [Full Text] [Related]  

  • 19. [Micrococcus blood stream infection in patients receiving epoprostenol].
    Mitsutake K; Nogami T
    Kansenshogaku Zasshi; 2005 Oct; 79(10):829-30. PubMed ID: 16296331
    [No Abstract]   [Full Text] [Related]  

  • 20. Continuous epoprostenol therapy and septal defect closure in a patient with severe pulmonary hypertension.
    Hirabayashi A; Miyaji K; Akagi T
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):688-91. PubMed ID: 19133673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.